FDA Approves Second Generic Abortion Pill, Faces GOP Criticism

The FDA's approval of a second generic mifepristone represents the agency properly following scientific evidence and legal requirements. Career scientists evaluated the medication's safety and effectiveness, continuing decades of established regulatory processes. This decision expands affordable healthcare options for patients while maintaining the same safety standards that have protected women for 25 years.